EO Faurecia SA

FORVIA: Total number of voting rights and shares forming the share capital

FORVIA: Total number of voting rights and shares forming the share capital

Nanterre, 8 October 2025

Total number of voting rights and shares forming the share capital

(Article L. 233-8 II of the French Commercial Code and

Article 223-16 of the General Regulation of the French Financial Markets Authority)

__________________

Trading place: Euronext Paris

Compartment: A

ISIN Code: FR0000121147

LEI Code: 969500F0VMZLK2IULV85

DateNumber of sharesTotal number of theoretical voting rights (1)Total number of exercisable voting rights (2)
30 September 2025197,089,340231,813,575219,579,427

(1) In accordance with the provisions of Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of voting rights (theoretical) is calculated on the basis of all the shares to which voting rights are attached, including the shares deprived of voting rights.

(2) Exercisable voting rights = total number of voting rights attached to the total number of shares less shares deprived of voting rights.

Inclusion in the bylaws of a clause that requires crossing thresholds declaration in addition to that related to legal thresholds: yes.

Attachment



EN
08/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Faurecia SA

Carole Braudeau
  • Carole Braudeau

Credit Morning 10/20/2025

Kering announces the sale of Kering Beauté to L'Oréal for € 4bn. Coty is expected to lose the Gucci licence when it expires.|Iliad: upgrade still a possibility at S&P despite the joint offer on Altice France|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/10/2025

Kering annonce la cession de Kering Beauté à L’Oréal pour 4 mds EUR. Coty devrait perdre la licence Gucci à échéance.|Iliad : upgrade toujours possible chez S&P malgré l’offre conjointe sur Altice France|

Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch